Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Iscience|November 2, 2023
MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cellsNami Yamashita, Henry Withers, Yoshihiro Morimoto, et al.
Thoracic Cancer|August 13, 2022
Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinomaAsato Hashinokuchi, Naoki Haratake, Tomoyoshi Takenaka, et al.
Anticancer Research|June 1, 2018
Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung CancerGouji Toyokawa, Kazuki Takada, Tetsuzo Tagawa, et al.
International Journal of Cancer|May 2, 2020
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapyShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cellsYoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, et al.
Cell Death Discovery|August 8, 2025
Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cellsNaoki Haratake, Shinkichi Takamori, Hideko Isozaki, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 27, 2023
Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapyKenji Watanabe, Fumihiko Kinoshita, Tomoyoshi Takenaka, et al.
Cancer Science|August 11, 2023
MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinomaTakayuki Nakanishi, Yasuto Yoneshima, Koji Okamura, et al.
Interactive Cardiovascular and Thoracic Surgery|October 20, 2017
Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective studyFumihiro Shoji, Naoko Miura, Taichi Matsubara, et al.
Biomedicines|July 27, 2024
MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare CancerHiroki Ozawa, Naoki Haratake, Ayako Nakashoji, et al.
Pageof 12